LYCOS RETRIEVER 
Patent: Patent No
built 661 days ago
Patent ductus arteriosus (PDA) is a heart problem that occurs soon after birth in some babies. In PDA, there is an abnormal circulation of blood between two of the major arteries near the heart. Before birth, the two major arteries—the aorta and the pulmonary artery—are normally connected by a blood vessel called the ductus arteriosus, which is an essential part of the fetal circulation. After birth, the vessel is supposed to close within a few days as part of the normal changes occurring in the baby's circulation. In some babies... the ductus arteriosus remains open (patent). This opening allows blood to flow directly from the aorta into the pulmonary artery, which can put a strain on the heart and increase the blood pressure in the lung arteries.
Source:
Patent litigation is tremendously expensive. And noisy. The ruckus has stirred quite a crowd: fat geezers with political heft to match are jostling to shuffle the seating arrangements in the patent spat ballroom. The stakes for infringers can stray to six to nine figures or more. Microsoft keeps a small army of patent litigators marching on the defense of 30 to 40 contemporaneous assertions. Though not as bad a barrage as Microsoft, quite a few large firms face regular patent battles.
Source:
Design Patents: A design patent protects ornamental designs for manufactured items. While the design may not change the utility of the invention, the design, shape or other ornamental feature may still be protected by patent. Design patents last for fourteen years after the date that the patent is issued.
Source:
In yesterday's decision, the court specifically denied Sun's motion for summary judgment of non-infringement of MedImmune's U.S. Patent No. 5,591,731 (the '731 patent). At the same time, the court granted Sun's motion for summary judgment in part, ruling that Sun's proposed amifostine product does not infringe a different patent, U.S. Patent No. 5,424,471 (the '471 patent). The '731 and '471 patents cover Ethyol.
Source:
IP Holdings LLC is an IP-centric merchant banking organization affiliated with General Patent Corporation International. IP Holdings provides patent brokerage services assisting clients in acquiring or selling patent and other IP assets. IP Holdings operates an idea incubator, which invests in, develops, incubates, and assists in the commercialization of novel and promising technology, with a particular emphasis on the development and protection of intellectual property. The idea incubator, which was started by General Patent Corporation and was featured in 1989 Marketing Computers Magazine’s cover story “Poltorak’s Business Incubator” [29] was spun off from GPC in 2000. IP Holdings’ portfolio companies include: Advanced Card Technologies LLC, Moen Technologies LLC, Leighton Technologies LLC, Digital Technology Licensing LLC, Advanced Video Technologies LLC[30], Ryogen LLC[31], Trounson Automation LLC, Interactive Telegames LLC and Home Equity Exchange LLC.
Source:
PITTSBURGH, July 26 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that U.S. Patent No. 7,070,808 was issued to its subsidiary, Mylan Technologies Inc. (MTI), on July 4, 2006. The '808 Patent contains one or more claims which cover the EMSAM® transdermal product, which is indicated for the treatment of major depressive disorder.
Source:
MORE ABOUT
Patent No